Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes

Authors

  • J.-M. Tiercy,

    Corresponding author
       PD Dr Jean-Marie Tiercy, National Reference Laboratory for Histocompatibility, Transplantation Immunology Unit, University Hospital, 24 rue Micheli-du-Crest, 1211 Geneva 14, Switzerland. Tel: 41 22 37 29 401; Fax: 41 22 37 29 390; E-mail: jean-marie.tiercy@medecine.unige.ch
    Search for more papers by this author
    • *

       Transplantation Immunology Unit, University Hospital, Geneva, Switzerland,

  • S. G. E. Marsh,

    Search for more papers by this author
    •  Anthony Nolan Research Institute, London, UK,

  • G. M. Th. Schreuder,

    Search for more papers by this author
    •  Department of Immunohematology and Blood Transfusion, University Medical Center, Leiden, the Netherlands,

  • E. Albert,

    Search for more papers by this author
    • § Labor für Immungenetik, Kinderpoliklinik, München, Germany,

  • G. Fischer,

    Search for more papers by this author
    •  Department for Blood Group Serology, Allgemeines Kranckenhaus, Vienna, Austria, and

  • R. Wassmuth,

    Search for more papers by this author
    • ** 

      University of Duesseldorf Medical Center, Germany

  • (European Federation for Immunogenetics subcommittee for reporting HLA ambiguities)


 PD Dr Jean-Marie Tiercy, National Reference Laboratory for Histocompatibility, Transplantation Immunology Unit, University Hospital, 24 rue Micheli-du-Crest, 1211 Geneva 14, Switzerland. Tel: 41 22 37 29 401; Fax: 41 22 37 29 390; E-mail: jean-marie.tiercy@medecine.unige.ch

No abstract is available for this article.

Ancillary